GLYC
GlycoMimetics Inc
Halal Rating :
Last Price
$0.26
Last updated:
Market Cap
-
7D Change
4.46%
1 Year Change
-91.6%
Company Overview
Industries
Exchange
Next Earnings Date
GlycoMimetics Inc is a clinical-stage biotechnology company focused on discovering and developing novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. The company's drug development program leverages its expertise in carbohydrate chemistry and knowledge of carbohydrate biology to develop novel medicines for diseases with high unmet need, particularly in hematology, oncology and inflammatory diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate GlycoMimetics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.